MBIO logo

Mustang Bio (MBIO)

Profile

Full Name

Mustang Bio, Inc.

Ticker Symbol

MBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 22, 2017

Indexes

Not included

Website

http://www.mustangbio.com

Employees

6

Key Details

Price

$1.34(-1.47%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$8.65(+83.02% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.34
MBIO price is $1.34

30-Day Relative Volume

0.13
MBIO 30-day relative volume is 0.13

Price Performance

Price Most recent change

-1.47%
MBIO price was down -1.47% on Apr 16, 2025

Price YTD change

-84.86%
MBIO price is down -84.86% since January 1st

Price 1-year change

-93.02%
MBIO price is down -93.02% year-on-year

Price 3-year change

-99.79%
MBIO price is down -99.79% over the past 3 years

Price Range

Price All-time high

$9825.00
MBIO price is currently -99.99% below its historical high of $9825.00

Price 3-year low

$0.13
MBIO price is currently +946.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.69M
MBIO market capitalization is $3.69 million

Market cap 3-year change

-96.99%
MBIO market capitalization is down -96.99% over the past 3 years

Market cap All-time high

$931.29M
MBIO market capitalization is currently -99.60% below its historical high of $931.29 million

Market cap sector rank

10.28%
MBIO market capitalization is higher than 10.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+165.9%
MBIO shares outstanding is up +165.9% year-on-year

Shares Outstanding 3-Year Change

+1349.5%
MBIO shares outstanding is up +1349.5% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.60
MBIO beta is 1.60

200-day SMA

$10.05
MBIO price is currently -86.66% below its 200-day simple moving average

50-day SMA

$1.88
MBIO price is currently -28.89% below its 50-day simple moving average

RSI

37.55
MBIO 14-day relative strength index is 37.55

Volume

0.13
MBIO 30-day relative volume is 0.13

ATR

$0.12
MBIO average true range is $0.12

10-day Historical Volatility

99.18%
MBIO 10-day historical volatility is 99.18%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
MBIO annual revenue value is unknown

Revenue Analysts estimate

-
MBIO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
MBIO annual revenue 1-year change is unknown

Revenue Sector rank

-
MBIO annual revenue is unknown

EPS

EPS

-$8.65
MBIO annual earnings per share is -$8.65

EPS Analysts estimate

-$17.50
MBIO annual earnings per share is currently -50.56% lower than the consensus analysts' forecast

EPS 1-year change

+83.02%
MBIO annual earnings per share is up +83.02% year-on-year

EPS Sector rank

13.06%
MBIO annual earnings per share is higher than 13.06% of companies in Healthcare sector

Profit

Gross profit

-
MBIO annual gross profit value is unknown

Gross margin

-
MBIO annual gross profit margin value is unknown

Operating profit

-$12.55M
MBIO annual operating income is -$12.55 million

Operating margin

-
MBIO annual operating profit margin value is unknown

Net income

-$15.75M
MBIO annual net profit is -$15.75 million

Net margin

-
MBIO annual net profit margin value is unknown

Expenses

Total expenses

$12.55M
MBIO annual total expenses is $12.55 million

Operating expenses

$12.55M
MBIO annual total operating expenses is $12.55 million

Cost of goods sold

-
MBIO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.13M
MBIO annual SGA is $4.13 million

Depreciation and amortization

$823.00K
MBIO annual depreciation & amortization is $823.00 thousand

Interest expense

$5000.00
MBIO annual interest expense is $5000.00

Income tax

-
MBIO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$15.75M
MBIO annual earnings before interest & taxes is -$15.75 million

EBITDA

-$14.92M
MBIO annual EBITDA is -$14.92 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.31M
MBIO annual total assets is $9.31 million

Non current assets

$702.00K
MBIO annual long term assets is $702.00 thousand

Current assets

$8.61M
MBIO annual total current assets is $8.61 million

Cash and cash equivalents

$6.84M
MBIO annual cash & cash equivalents is $6.84 million

Accounts receivable

-
MBIO annual accounts receivable value is unknown

Inventory

-
MBIO annual inventory value is unknown

Liabilities

Total liabilities

$13.18M
MBIO annual total liabilities is $13.18 million

Long term liabilities

$572.00K
MBIO annual total long term liabilities is $572.00 thousand

Current liabilities

$12.61M
MBIO annual total current liabilities is $12.61 million

Accounts payable

$7.46M
MBIO annual accounts payable is $7.46 million

Debt

Total debt

$878.00K
MBIO annual total debt is $878.00 thousand

Total debt 1-year change

-64.85%
MBIO annual total debt is down -64.85% year-on-year

Long term debt

$422.00K
MBIO annual long term debt is $422.00 thousand

Short term debt

$456.00K
MBIO annual short term debt is $456.00 thousand

Equity & Capital

Shareholders equity

-$3.87M
MBIO annual stockholders equity is -$3.87 million

Book value

-$3.87M
MBIO annual book value is -$3.87 million

Retained earnings

-$396.72M
MBIO annual retained earnings is -$396.72 million

Working capital

-$4.00M
MBIO annual working capital is -$4.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.41M
MBIO annual cash flow from operations is -$11.41 million

Cash from operations 1-year change

+76.94%
MBIO annual cash flow from operations is up +76.94% year-on-year

Cash from investing

$0.00
MBIO annual cash flow from investing activities is $0.00

Cash from investing 1-year change

-100%
MBIO annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$11.27M
MBIO annual cash flow from financing activities is $11.27 million

Cash from financing 1-year change

+143.19%
MBIO annual cash flow from financing activities is up +143.19% year-on-year

CAPEX

CAPEX

-
MBIO annual capital expenditures value is unknown

CAPEX 1-year change

-
MBIO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$11.41M
MBIO annual free cash flow is -$11.41 million

Free cash flow 1-year change

+76.99%
MBIO annual free cash flow is up +76.99% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MBIO annual gross profit margin value is unknown

Operating margin

-
MBIO annual operating profit margin value is unknown

Net margin

-
MBIO annual net profit margin value is unknown

ROA & ROE

ROA

-169.23%
MBIO annual return on assets is -169.23%

ROE

406.71%
MBIO annual return on equity is 406.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MBIO price to earnings ratio value is unknown

PE ratio Sector rank

-
MBIO price to earnings ratio is unknown

PB Ratio

PB ratio

-0.95
MBIO price to book ratio is -0.95

PB ratio Sector rank

8.81%
MBIO price to book ratio is higher than 8.81% of companies in Healthcare sector

PS Ratio

PS ratio

-
MBIO price to sales ratio value is unknown

PS ratio Sector rank

-
MBIO price to sales ratio is unknown

Enterprise value

Enterprise value

-$2.27M
MBIO enterprise value is -$2.27 million

Enterprise value Sector rank

8.67%
MBIO enterprise value is higher than 8.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.15
MBIO EV/EBITDA is 0.15

EV/EBITDA Sector rank

68.17%
MBIO EV/EBITDA is higher than 68.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.68
MBIO annual current ratio is 0.68

Quick ratio

-
MBIO annual quick ratio value is unknown

Leverage

Debt to equity

-0.23
MBIO annual debt to equity ratio is -0.23

Interest coverage ratio

-3149.40
MBIO annual interest coverage ratio is -3149.40

Risk & Stability

Piotroski F-Score

-
MBIO piotroski f-score value is unknown

Altman Z-Score

-
MBIO altman z-score value is unknown

Analyst ratings

Recent major analysts updates

May 16, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Aug 24, 23 Cantor Fitzgerald
Overweight
Aug 16, 23 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
Aug 15, 23 BTIG
Buy
Jun 16, 23 HC Wainwright & Co.
Buy
Jun 16, 23 BTIG
Buy
May 15, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MSPR logo
MSP Recovery (MSPR)
JAGX logo
Jaguar Health (JAGX)
KTTA logo
Pasithea Therapeutics (KTTA)
GENE logo
Genetic Technologies Limited (GENE)
TOVX logo
Theriva Biologics (TOVX)
XBIO logo
Xenetic Biosciences (XBIO)
PRFX logo
PainReform (PRFX)
RDHL logo
RedHill Biopharma (RDHL)
RHE logo
Regional Health Properties (RHE)
  • What is the ticker symbol for Mustang Bio?
  • Does Mustang Bio pay dividends?
  • What sector is Mustang Bio in?
  • What industry is Mustang Bio in?
  • What country is Mustang Bio based in?
  • When did Mustang Bio go public?
  • Is Mustang Bio in the S&P 500?
  • Is Mustang Bio in the NASDAQ 100?
  • Is Mustang Bio in the Dow Jones?
  • When was Mustang Bio's last earnings report?
  • When does Mustang Bio report earnings?
  • Should I buy Mustang Bio stock now?

What is the ticker symbol for Mustang Bio?

The ticker symbol for Mustang Bio is NASDAQ:MBIO

Does Mustang Bio pay dividends?

No, Mustang Bio does not pay dividends

What sector is Mustang Bio in?

Mustang Bio is in the Healthcare sector

What industry is Mustang Bio in?

Mustang Bio is in the Biotechnology industry

What country is Mustang Bio based in?

Mustang Bio is headquartered in United States

When did Mustang Bio go public?

Mustang Bio's initial public offering (IPO) was on August 22, 2017

Is Mustang Bio in the S&P 500?

No, Mustang Bio is not included in the S&P 500 index

Is Mustang Bio in the NASDAQ 100?

No, Mustang Bio is not included in the NASDAQ 100 index

Is Mustang Bio in the Dow Jones?

No, Mustang Bio is not included in the Dow Jones index

When was Mustang Bio's last earnings report?

Mustang Bio's most recent earnings report was on Nov 8, 2024

When does Mustang Bio report earnings?

The next expected earnings date for Mustang Bio is May 15, 2025

Should I buy Mustang Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page